News | October 02, 2013

U.S. Proton Therapy Outlook 2017

October 2, 2013 — Proton therapy is the most advanced radiation technique available. Unfortunately, access to proton therapy is limited due to the low number of proton therapy centers. Research institutes and hospitals are now frequently investing in proton therapy to make it more accessible to patients.

According to the "US Proton Therapy Outlook 2017" by RNCOS, the United States will be home to almost 27 proton therapy centers by 2017, almost double the current figure, and attain revenue of $1.17 billion. The 65-page report provides an insight into the demographics and historical trend (2008-2013) of cancer incidences, deaths and prevalence along with statewide and site-wide cancer incidences in the United States.

The study dedicates a complete chapter on the various components of any proton therapy center and covers issues related to accelerators, delivery, transportation, planning and positioning systems to human resources required to setup a center.

The report further provides the statewide statistics of potential patients for proton therapy and the latter's current market penetration. It also includes a section dedicated to market opportunity assessment, which would help service providers and vendors to extract benefits from the largely untapped but lucrative market.

After a thorough analysis of the market, RNCOS has deduced various trends, drivers and challenges that will have a major influence on shaping the growing market. On the competitive front, the report covers the current stand and its probable transformation by 2017 for service providers and equipment vendors. Additionally, the report provides analyses of equipment vendors as well as their business overviews, products and services and existing and planned installations in the United States until 2017.

For more information: www.rncos.com

Related Content

RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...